Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-024530·BAYER HEALTHCARE LLC
Schedule 13D ownership disclosure
SENTI BIOSCIENCES INC
Common Stock, par value $0.0001 per share · CUSIP: 81726A100
Event date: 2025-03-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bayer HealthCare LLCReported CIK 0001231517
Shares: 6,142,848.00 · Class: 19.99%
- Bayer US Holding LLCReported CIK 0001965754
Shares: 6,142,848.00 · Class: 19.99%
- Sebastian Guth
Shares: 6,142,848.00 · Class: 19.99%
- Gurumurthy Ramamurthy
Shares: 6,142,848.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-024530
- Form type
- SCHEDULE 13D
- Filer
- BAYER HEALTHCARE LLC
- CIK
- CIK 1231517
- Filed
- Mar 17, 2025
- Reporting period
- Mar 10, 2025
- Description
- Schedule 13D beneficial ownership